Vetoquinol S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VETO.PA research report →
About the company
Vetoquinol S. A. is a prominent veterinary pharmaceutical enterprise dedicated to the innovation, development, and global commercialization of both medicinal and non-medicinal solutions for animal health.
- CEO
- Matthieu Frechin
- IPO
- 2006
- Employees
- 2,519
- HQ
- Lure, FR
Price Chart
- Market Cap
- $838.14M
- P/E
- 14.96
- P/S
- 1.59
- P/B
- 1.46
- EV/EBITDA
- 1.81
- Div Yield
- 1.29%
- Gross Margin
- 30.50%
- Op Margin
- 13.93%
- Net Margin
- 10.90%
- ROE
- 9.89%
- ROIC
- 8.96%
- Revenue
- $525.70M · -2.50%
- Net Income
- $57.30M · -2.36%
- EPS
- $4.94 · -0.80%
- Op Income
- $73.24M
- FCF YoY
- -24.65%
- 52W High
- $91.50
- 52W Low
- $67.20
- 50D MA
- $73.72
- 200D MA
- $78.21
- Beta
- 0.89
- Avg Volume
- 5.00K
Get TickerSpark's AI analysis on VETO.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our VETO.PA coverage
Recent articles, reports, and earnings notes.
No research on VETO.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VETO.PA report →Similar companies
Peers in the same neighborhood.